Ethyl pyruvate attenuates delayed experimental cerebral vasospasm following subarachnoid haemorrhage in rats: possible role of JNK pathway. Issue 14 (16th February 2018)

• Record Type: Journal Article
• Authors: Jin, Ke; Wu, Hui; Lv, Tao; Dai, Jiong; Zhang, Xiaohua; Jin, Yichao
• Is Part Of: RSC advances. Volume 8:Issue 14(2018)
• Page Start: 7726
• Page End: 7734
• Publication Date: 2018-02-16
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/c7ra10801j
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : The pathophysiology of delayed cerebral vasospasm (CVS) after subarachnoid haemorrhage (SAH) is multifaceted and involves endothelial apoptosis and inflammation. Abstract : The pathophysiology of delayed cerebral vasospasm (CVS) after subarachnoid haemorrhage (SAH) is multifaceted and involves endothelial apoptosis and inflammation. Ethyl pyruvate (EP) could attenuate early brain injury following SAH via anti-inflammation and inhibition of the c-Jun N-terminal kinase (JNK) signalling pathway. However, the role of EP in the delayed CVS has yet to be determined. In this study, we examined the effect of EP on endothelial apoptosis and inflammation and explore possible signalling pathways. We found that EP could significantly attenuate the delayed CVS. Possible mechanisms include a decrease in the endothelial cell apoptosis of the basilar artery and alleviation of endothelial inflammation. The JNK signalling pathway may play an important role in the neuroprotective effects of EP on delayed CVS. The results suggest that EP may be a possible therapy for delayed CVS, and the JNK signalling pathway should be targeted for therapeutic purposes in the future.